Effective and safe treatment of anti-CD38 therapy in systemic lupus erythematosus-associated refractory cerebral vasculitis induces immune tolerance
Rheumatology (Oxford)
.
2023 Feb 1;62(2):e21-e23.
doi: 10.1093/rheumatology/keac393.
Authors
Melek Yalcin Mutlu
1
2
,
Jochen Wacker
1
2
,
Koray Tascilar
1
2
,
Jule Taubmann
1
2
,
Bernhard Manger
1
2
,
Gerhard Krönke
1
2
,
Georg Schett
1
2
,
David Simon
1
2
Affiliations
1
Department of Internal Medicine 3.
2
Deutsches Zentrum fuer Immuntherapie (DZI), Friedrich-Alexander University (FAU) Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
PMID:
35801920
DOI:
10.1093/rheumatology/keac393
No abstract available
Publication types
Letter
MeSH terms
Humans
Immune Tolerance
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / drug therapy
Vasculitis, Central Nervous System* / drug therapy